Corrigendum: Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine

Marina Barrio-Calvo; Søren Vester Kofoed; Sofie Cens Holste; Anders Bundgård Sørensen; Nadia Viborg; Jens Vindahl Kringelum; Daniela Kleine-Kohlbrecher; Christian Skjødt Steenmans; Christian Bahne Thygesen; Birgitte Rønø; Stine Friis

doi:10.3389/fimmu.2023.1290431

Corrigendum: Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine

Front Immunol. 2023 Sep 14:14:1290431. doi: 10.3389/fimmu.2023.1290431. eCollection 2023.

Affiliation

¹ Evaxion Biotech, Hørsholm, Denmark.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1234912.].

Keywords: APC-targeting; CCL19; DNA vaccine; cancer immunotherapy; neoantigens.

Publication types

Published Erratum

Grants and funding

The Innovation Fund Denmark partially funded MB-C (1044-00028B) and NV (5189-00187B). The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.